SCHEMBL2434439

SCHEMBL2434439

COC(=O)CCC(=O)c1c(O)c2cc(C(=O)OC)cnc2n(C)c1=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.39
ALDH1A1 P00352 10/20 0.37
KDM4E B2RXH2 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
MAPT P10636 4/20 0.34
HPGD P15428 2/20 0.34
LMNA P02545 4/20 0.33
PKM P14618 2/20 0.33
TSHR P16473 1/20 0.33
PPARG P37231 1/20 0.33
MAPK10 P53779 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
MITF O75030 1/20 0.33
MAPK1 P28482 1/20 0.33
PAX8 Q06710 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2435402 0.86 EGLN1 (0.39) EGLN1ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL2434695 0.83 POLB (0.38) EGLN1ALDH1A1L3MBTL1MAPTHPGD
SCHEMBL2439467 0.80 CNR2 (0.37) EGLN1ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL2434564 0.80 EGLN1 (0.52) EGLN1ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL2438710 0.78 CNR2 (0.45) EGLN1SMN1; SMN2
SCHEMBL12291858 0.74 EGLN1 (0.53) EGLN1ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL2434416 0.73 ALDH1A1 (0.44) EGLN1ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL2443706 0.73 EGLN1 (0.52) EGLN1ALDH1A1KDM4EL3MBTL1MAPT
SCHEMBL2438136 0.70 EGLN1 (0.52) EGLN1ALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL2439372 0.70 EGLN1 (0.49) EGLN1ALDH1A1KDM4EL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142509-B1 QUINOLONES AND AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE AMGEN INC (US) 2013-12-04 EP disclosed
US-8349868-B2 Azaquinolones that inhibit prolyl hydroxylase AMGEN INC. (US) 2013-01-08 US disclosed
US-8048894-B2 Quinolones and azaquinolones that inhibit prolyl hydroxylase AMGEN INC. (US) 2011-11-01 US disclosed
US-20110224248-A1 AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE AMGEN INC. (US) 2011-09-15 US disclosed
EP-2144918-A1 FUNCTIONALIZED NANOPARTICLES BASF SE (DE) 2010-01-20 EP disclosed
EP-2142509-A2 QUINOLONES AND AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE Amgen, Inc (US) 2010-01-13 EP disclosed
US-20090156605-A1 Quinolones and azaquinolones that inhbit prolyl hydroxylase AMGEN INC. (US) 2009-06-18 US disclosed
WO-2008138727-A1 FUNCTIONALIZED NANOPARTICLES BASF SE (CH) 2008-11-20 WO disclosed
WO-2008130600-A2 QUINOLONES AND AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE AMGEN INC. (US) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156605-A1 Quinolones and azaquinolones that inhbit prolyl hydroxylase EGLN3, HIF1AN, EGLN2 EGLN1 6/4885ALDH1A1 191/4885KDM4E 336/4885
US-20110224248-A1 AZAQUINOLONES THAT INHIBIT PROLYL HYDROXYLASE HIF1AN, EGLN3, EGLN2 EGLN1 6/4885ALDH1A1 145/4885KDM4E 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.